Amphastar Pharmaceuticals (AMPH) Current Deferred Tax Assets (2013 - 2015)

Amphastar Pharmaceuticals' Current Deferred Tax Assets history runs 3 years deep, the most recent figure standing at $19.2 million for Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets rose 19.14% year-over-year to $19.2 million in Q3 2015; TTM through Sep 2015 was $19.2 million, a 19.14% increase from a year earlier, with the FY2014 full-year figure at $19.5 million, up 21.35% from the prior year.
• Current Deferred Tax Assets held at $19.2 million in Q3 2015 per AMPH's latest filing, from $19.2 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $19.7 million in Q1 2015 and bottomed at $16.1 million in Q4 2013.
• The 3-year median for Current Deferred Tax Assets is $19.2 million (2015), against an average of $18.0 million.
• Across the five-year window, Current Deferred Tax Assets grew 21.35% in 2014 and grew 19.14% in 2015, its largest moves.
• Year by year, Current Deferred Tax Assets stood at $16.1 million in 2013, then advanced by 21.35% to $19.5 million in 2014, then dropped by 1.83% to $19.2 million in 2015.
• Per Business Quant, the three latest AMPH Current Deferred Tax Assets figures stand at $19.2 million (Q3 2015), $19.2 million (Q2 2015), and $19.7 million (Q1 2015).